ESTABLISHMENT OF A HUMAN HEPATIC ADENOSQUAMOUS CARCINOMA CELL-LINE (KMC-2) AND ITS RESPONSE TO CYTOKINES

被引:4
作者
MOMOSAKI, S
YANO, H
KOJIRO, M
机构
[1] First Department of Pathology, Kurume University, School of Medicine, Kurume
关键词
ADENOSQUAMOUS CARCINOMA; CELL LINE; CHOLANGIOCELLULAR CARCINOMA; CYTOKINES; LIVER; SQUAMOUS METAPLASIA;
D O I
10.1111/j.1440-1827.1995.tb03434.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A human hepatic adenosquamous carcinoma cell line (KMC-2) was established from a serially transplanted tumor in nude mice (nuKMC-2), which originated from human cholangiocellular carcinoma and showed histological alteration from adenocarcinoma to squamous cell carcinoma (SCC) along with serial transplantation. KMC-2 cells in monolayer culture proliferated in a sheet-like arrangement with a population doubling time of 29.5 h, whereas the cells in 0.1% collagen gel embedded culture formed a compact and tubular structure with the population doubling time of 35.4 h. The cells secreted carbohydrate antigen 19-9 (CA19-9), tissue polypeptide antigen and SCC-related antigen. The back-transplanted nude mouse turner exhibited morphologic features of adenosquamous carcinoma resembling those in the original nude mouse tumor. IFN-alpha, IFN-gamma and TNF-alpha suppressed cell proliferation significantly. Functionally, IFN-gamma significantly suppressed CA19-9 secretion, and conversely promoted SCC-related antigen secretion. These findings suggest that KMC-2 is the first human hepatic adenosquamous carcinoma cell line primarily originated from adenocarcinoma; the environmental factors, such as the presence of extracellular matrix and the cytokines influenced the growth, morphology end function of KMC-2.
引用
收藏
页码:137 / 146
页数:10
相关论文
共 30 条
[1]  
BARR RJ, 1975, GASTROENTEROLOGY, V69, P1326
[2]  
BLOUSTEIN PA, 1976, CANCER, V38, P2002, DOI 10.1002/1097-0142(197611)38:5<2002::AID-CNCR2820380523>3.0.CO
[3]  
2-9
[4]  
CHANG EH, 1987, P SOC EXP BIOL MED, V186, P319
[5]   SQUAMOUS-CELL CARCINOMA OF THE LIVER [J].
GRESHAM, GA ;
RUE, LW .
HUMAN PATHOLOGY, 1985, 16 (04) :413-416
[6]  
HARAMAKI M, 1993, ACTA PATHOL JAPON, V43, P490
[7]  
HASEGAWA M, 1991, HUM CELL, V4, P56
[8]  
HOMMA S, 1987, Gastroenterologia Japonica, V22, P474
[9]   A NEW HUMAN CHOLANGIOCELLULAR CARCINOMA CELL-LINE (KMC-1) [J].
IEMURA, A ;
MARUIWA, M ;
YANO, H ;
KOJIRO, M .
JOURNAL OF HEPATOLOGY, 1992, 15 (03) :288-298
[10]  
IEMURA A, 1992, CANCER, V70, P415